Name: in vitro differentiation model of human normal memory b cells to long-lived plasma cells
Uploaded: 2019-01-20T14:30:00.000+00:00
Duration: 10 min 26 s
Description: Watch this Scientific Journal Video about In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells at JoVE.com

This work was supported by grants from French INCA (Institut National du Cancer) Institute (PLBIO15-256), ANR (Tie-Skip) and ITMO Cancer (MM&#38;TT).

The protocol follows the guidelines in accordance with the Declaration of Helsinki and agreement of the Montpellier University Hospital Centre for Biological Resources.
1. In Vitro Normal Plasma Cell Differentiation Model
NOTE: PCs are generated through a four-step culture11,12,13.
<ol>
	<li>B cell amplification and differentiation
	<ol>
		<li>Use peripheral blood cells from healthy volunteers for memory B cell purification.</li>
		<li>Dilute 7.5 mL of blood with 24.5 mL of RPMI 1640 medium.</li>
		<li>Add 12.5 mL of room temperature density gradient (e.g., Ficoll) to a sterile 50 mL conical tube. Gently overlay the density gradient with the 32 mL of diluted blood. Minimize the mixing of the two phases.</li>
		<li>Centrifuge 20 min at 500 x g with the brake off. Collect the PBMCs from the diluted plasma/density gradient interface and place the cells in a sterile 50 mL tube and complete to 45 mL with Hank&#39;s balanced salt solution.</li>
		<li>Centrifuge the cells for 5 min at 500 x g. Carefully remove the supernatant and keep the pellet.</li>
		<li>Add 45 mL of RPMI1640/10% fetal calf serum (FCS) and centrifuge 5 min at 500 x g. Carefully remove the supernatant and keep the pellet. Add 30 mL of PBS/2% FCS.</li>
		<li>Remove CD2+ cells using anti-CD2 magnetic beads. Add 4 beads for one target cell. Incubate 30 min at 4 &#176;C.
		<ol>
			<li>Separate bead-bound cells from unbound cells using a magnet for cell separation application. Collect unbound cells and incubate the cell pellet with anti CD19 APC and anti CD27 PE antibodies for 15 minutes at 4 &#176;C (2 &#181;L of antibody for 106 cells).</li>
			<li>Wash twice in PBS/10% goat serum.</li>
			<li>Remove contaminating events on both FSC and SSC plots. Plot singlets on FSC-A vs FSC-H and SSC-A vs SSC-H plots to remove debris and to select the total leukocyte population. Select memory B cells on CD19/CD27 and CD19+CD27+.</li>
			<li>Purify MBCs using a cell sorter with a 95% purity.</li>
		</ol>
		</li>
		<li>Perform all the culture steps using IMDM and 10% FCS, supplemented with 50 mg/mL human transferrin and 5 mg/mL human insulin.</li>
		<li>Plate purified MBCs in six-well culture plates (1.5 x 105 MBCs/mL in 5 mL/well), for 4 days, with IL-2 (20 U/mL), IL-10 (50 ng/mL), and IL-15 (10 ng/mL).
		<ol>
			<li>Add Phosphorothioate CpG ODN 2006, histidine-tagged recombinant human soluble CD40L (sCD40L; 50 ng/mL) and anti-polyhistidine mAb (5 mg/mL) for MBCs activation (Figure 1). Activation by sCD40L or ODN only with the same cytokine cocktail yields to lower amplification12. The combination of activation signals described here leaded to the maximum number of activated B cells and PrePBs11,12 (Figure 1).</li>
			<li>For gene expression profiling, purify CD38-/CD20- PrePBs, at day 4, using a cell sorter (Figure 2).</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>Plasmablastic cell generation
	<ol>
		<li>At day 4, count the cells.</li>
		<li>Plate cells in 12-well culture plates at 2.5 x 105/mL in 2 mL/well.</li>
		<li>Induce differentiation by removal of CpG oligonucleotides and sCD40L and addition of a new culture medium with a new cytokine cocktail including IL-2 (20 U/mL), IL-6 (50 ng/mL), IL-10 (50 ng/mL) and IL-15 (10 ng/mL) (Figure 1). Culture cells for 3 days (from day 4 to day 7) at 37 &#176;C.</li>
		<li>For gene expression profiling, purify CD38+/CD20- PBs, at day 7, using a cell sorter (Figure 2).</li>
	</ol>
	</li>
	<li>Early plasma cell generation
	<ol>
		<li>At day 7, count the cells.</li>
		<li>Plate cells in 12-well culture plates at 5 x 105/mL in 2 mL/well.</li>
		<li>Differentiate PB in early PCs using fresh culture medium with IL-6 (50 ng/mL), IL-15 (10 ng/mL) and IFN-&#945; (500 U/mL) for 3 days at 37 &#176;C. For gene expression profiling, purify CD20-/CD38+/CD138+ early PCs, at day 10, using a cell sorter (Figure 2).</li>
	</ol>
	</li>
	<li>Long-lived plasma cell generation
	<ol>
		<li>Differentiate Early PCs into long lived PCs by changing the culture conditions.</li>
		<li>Culture the cells in 12-well culture plates at 5 x 105/mL in 2 mL/well or in 24-well culture plates in 1 mL/well at 37 &#176;C, using IL-6 and stromal cell conditioned medium and APRIL (200 ng/mL).</li>
		<li>Obtain stromal cell-conditioned medium by culturing stromal cells for 5 days with culture medium. Filter the stromal cell culture supernatant (0.2 &#181;m) and freeze.</li>
		<li>Add 50% of stromal cell-conditioned media to PC cultures with renewal every week. Generated long-lived PCs could be maintained for months13. Long term survival of PCs could be obtained with IL-6 and APRIL only as reported13.</li>
		<li>Measure Ig secretion from flow cytometry sorted PCs.</li>
		<li>Culture PCs at 106 cells/mL for 24 h and harvest culture supernatant. Measure IgG and IgA using human enzyme-linked immunosorbent assay (ELISA) kits11,12,13. The median IgG secretion ranged from 10 pg/cell/day at day 10 to 17 pg/cell/day at day 6013.</li>
	</ol>
	</li>
</ol>
2. Molecular Atlas of B to PC Differentiation
NOTE: We built a convenient and open access bioinformatics tools to extract and visualize the most prominent information from Affymetrix GEP data related to PC differentiation (GenomicScape)15. GEP are publicly available from ArrayExpress database (http://www.ebi.ac.uk/arrayexpress/) including purified MBCs, PrePBs, PBs and EPCs: E-MTAB-1771, E-MEXP-2360 and E-MEXP-3034 and BMPC E-MEXP-236014,15. Genomicscape is a freely available webtool.
<ol>
	<li>Selection of B to PC dataset
	<ol>
		<li>Select B to PC dataset in the Browse Data menu in GenomicScape open access bioinformatic tool (http://www.genomicscape.com) called Human B cells to plasma cells. Visualization of gene expression profile of unique gene or a list of genes is available using the Expression-Coexpression Report tool in the Analysis Tools available in the home page.</li>
	</ol>
	</li>
	<li>Supervised analysis and principal component analysis (PCA)
	<ol>
		<li>Select Analysis Tools | webSAM to load the SAM tool.</li>
		<li>Choose the Human B cells to plasma cells dataset and select the groups of samples to compare.</li>
		<li>Use the different filters available to apply the filtering options of interest.</li>
		<li>To compare gene expression profiles with SAM tool, modify the filtering options including Fold change, number of permutations, False discovery rate and the type of comparison. GenomicScape will compute the analysis and provide genes differentially expressed between the selected groups.</li>
		<li>Run principal component analysis by selecting Principal Component Analysis in Analysis Tools menu.</li>
		<li>Choose the Human B cells to plasma cells dataset and select the groups of interest.</li>
		<li>Paste a list of genes of interest or select genes according to the variance. To paste a list of genes, select To analyse a list of genes/ncRNAs, click here&#8230;. Genomicscape will compute PCA that could be visualized and downloaded.</li>
	</ol>
	</li>
</ol>

The authors have nothing to disclose

In human, PC are rare cells with differentiation stages taking place in anatomic places that hamper full biological characterization. We have developed an in vitro B to PC differentiation model using multi-step culture systems where various combinations of activation molecules and cytokines are subsequently applied in order to reproduce the sequential cell differentiation occurring in the different organs/tissues in vivo11,12,13...

The differentiation of B cells to plasma cells (PCs) is essential for humoral immunity and protect the host against infections1. B to PC differentiation is associated with major changes in transcription capacity and metabolism to accommodate to antibody secretion.The transcription factors that control B to PC differentiation have been extensively studied and revealed exclusive networks including B- and PC-specific transcription factors (TFs)2. In B cells, PAX5, BCL6 and BACH2 TFs are the guardians of B cell identity2,3. Induction of IRF4, PRDM1 encoding BLIMP1 and XBP1 PC TF will extinguish B cell genes and induce a coordinated antibody-secreting cell transcriptional program3,4,5. These coordinated transcriptional changes are associated with Ig genes transcription activation together with a switch from the membrane-bound form to the secreted form of the immunoglobulin heavy chain2,3,4. B to PC differentiation is linked with induction of genes involved in endoplasmic reticulum and Golgi apparatus functions concomitant with unfolded protein response (UPR) activation known to play a key role in PC by accommodating the synthesis of secreted immunoglobulins6,7. The TF XBP1 plays a major role in this cellular adaptation8,9,10.
B cells and PCs are key players of humoral immunity. Understanding the biological processes that control the production and the survival of normal plasma cells is critical in therapeutic interventions that need to ensure efficient immune responses and prevent autoimmunity or immune deficiency. PC are rare cells with early differentiation stages taking place in anatomic locations that hamper full biological characterization, particularly in human. Using multi-step culture systems, we have reported an in vitro B to PC differentiation model. This model reproduces the sequential cell differentiation and maturation occurring in the different organs in vivo11,12,13.&#160;In a first step, memory B cells are first activated for four days by CD40 ligand, oligodeoxynucleotides and cytokine combination and differentiate into preplasmablasts (PrePBs). In a second step, preplasmablasts are induced to differentiate into plasmablasts (PBs) by removing CD40L and oligodeoxynucleotides stimulation and changing the cytokine combination. In a third step, plasmablasts are induced to differentiate into early PCs by changing the cytokine combination11,12. A fourth step was introduced to get fully mature PCs by culturing these early PCs with bone marrow stromal cells conditioned medium or selected growth factors13. These mature PCs could survive several months in vitro and secrete high amounts of immunoglobulin (Figure 1). Interestingly, our in vitro model recapitulates the coordinated transcriptional changes and the phenotype of the different B to PC stages that can be detected in vivo11,12,13,14,15. PCs are rare cells and our in vitro differentiation model allows to study human B to PC differentiation.

<table><tbody><tr><td>anti-CD2 magnetic beads</td><td>Invitrogen</td><td>11159D</td><td></td></tr><tr><td>Anti-CD138-APC</td><td>Beckman-Coulter&amp;nbsp;</td><td>B49219</td><td></td></tr><tr><td>Anti-CD19-APC</td><td>BD</td><td>555415</td><td></td></tr><tr><td>Anti-CD20-PB</td><td>Beckman-Coulter&amp;nbsp;</td><td>B49208</td><td></td></tr><tr><td>Anti-CD27-PE</td><td>BD</td><td>555441</td><td></td></tr><tr><td>Anti-CD38-PE</td><td>Beckman-Coulter&amp;nbsp;</td><td>A07779</td><td></td></tr><tr><td>Anti-histidine</td><td>R&amp;amp;D Systems</td><td>MAB050</td><td></td></tr><tr><td>CpG ODN(PT)</td><td>Sigma</td><td></td><td>T*C*G*T*C*G*T*T*T*T*G*T*C*&lt;br/&gt; G*T*T*T*T*G*T*C*G*T*T</td></tr><tr><td>human Transferin</td><td>Sigma-Aldrich</td><td>T3309</td><td></td></tr><tr><td>IFN-&amp;alpha;</td><td>Merck</td><td>Intron A</td><td></td></tr><tr><td>IMDM</td><td>Gibco</td><td>31980-022</td><td></td></tr><tr><td>Recombinan Human CD40L-hi</td><td>R&amp;amp;D Systems</td><td>2706-CL</td><td></td></tr><tr><td>Recombinant Human APRIL</td><td>R&amp;amp;D Systems</td><td>5860-AP-010</td><td></td></tr><tr><td>Recombinant Human IL-10</td><td>R&amp;amp;D Systems</td><td>217-IL-</td><td></td></tr><tr><td>Recombinant Human IL-15</td><td>Peprotech</td><td>200-15-10ug</td><td></td></tr><tr><td>Recombinant Human IL-2 Protein</td><td>R&amp;amp;D Systems</td><td>202-IL-</td><td></td></tr><tr><td>Recombinant Human IL-6</td><td>Peprotech</td><td>200-06</td><td></td></tr></tbody></table>

in vitro differentiation model of human normal memory b cells to long-lived plasma cells

Plasma cells (PCs) secrete large amounts of antibodies and develop from B cells that have been activated. PCs are rare cells located in the bone marrow or mucosa and ensure humoral immunity. Due to their low frequency and location, the study of PCs is difficult in human. We reported a B to PC in vitro differentiation model using selected combinations of cytokines and activation molecules that allow to reproduce the sequential cell differentiation occurring in vivo. In this in vitro model, memory B cells (MBCs) will differentiate into pre-plasmablasts (prePBs), plasmablasts (PBs), early PCs and finally, into long-lived PCs, with a phenotype close to their counterparts in healthy individuals.&#160;We also built an open access bioinformatics tools to analyze the most prominent information from GEP data related to PC differentiation. These resources can be used to study human B to PC differentiation and in the current study, we investigated the gene expression regulation of epigenetic factors during human B to PC differentiation.

The overall procedure of in vitro normal PC differentiation is represented in Figure 1. Using the protocol presented here, we could generate adequate quantity of cells that could not be obtained with ex vivo human samples. Although the role of the complex network of transcription factors involved in PC differentiation has been investigated, the mechanisms regulating key PC differentiation transcription networks remain poorly known. Cellular differentiation is...

Watch this Scientific Journal Video about In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells at JoVE.com

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Using multi-step culture systems, we report an in vitro B cell to plasma cell differentiation model.

Plasma cells (PCs) secrete large amounts of antibodies and develop from B cells that have been activated. PCs are rare cells located in the bone marrow or ...

in-vitro-differentiation-model-human-normal-memory-b-cells-to-long

Research

JoVE Journal

Immunology and Infection

12.0K Views.  Univ Montpellier. Using multi-step culture systems, we report an in vitro B cell to plasma cell differentiation model.

Video: In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants

The inheritance of pre-rearranged T cell receptors (TCRs) and their epigenetic rejuvenation make induced pluripotent stem cell (iPSC)-derived T cells a promising source for adoptive T cell therapy (ACT). However, classical in vitro methods for producing regenerated T cells from iPSC result in either innate-like or terminally differentiated T cells, which are phenotypically and functionally distinct from na&#239;ve T cells. Recently, a novel three-dimensional (3D) thymic culture system was developed to generate a homogenous subset of CD8&#945;&#946;+ antigen-specific T cells with a na&#239;ve T cell-like functional phenotype, including the capacity for proliferation, memory formation, and tumor suppression in vivo. This protocol avoids aberrant developmental fates, allowing for the generation of clinically relevant iPSC-derived T cells, designated as iPSC-derived thymic emigrants (iTE), while also providing a potent tool to elucidate the subsequent functions necessary for T cell maturation after thymic selection.

This article describes a novel method to generate tumor antigen-specific induced pluripotent stem cell-derived thymic emigrants (iTE) by a three-dimensional (3D) thymic culture system. iTE are a homogenous subset of T cells closely related to na&#239;ve T cells with the capacity for proliferation, memory formation, and tumor suppression.

The inheritance of pre-rearranged T cell receptors (TCRs) and their epigenetic rejuvenation make induced pluripotent stem cell (iPSC)-derived T cells a ...

Cancer Research

Generation of Induced Regulatory T Cells from Primary Human Na&iuml;ve and Memory T Cells

The development and maintenance of immunosuppressive CD4+ regulatory T cells (Tregs) contribute to the peripheral tolerance needed to remain in immunologic homeostasis with the vast amount of self and commensal antigens in and on the human body. Perturbations in the balance between Tregs and inflammatory conventional T cells can result in immunopathology or cancer. Although therapeutic injection of Tregs has been shown to be efficacious in murine models of colitis1 , type I diabetes2 , rheumatoid arthritis and graft versus host disease,4 several fundamental differences in human versus mouse Treg biology5 has thus far precluded clinical use. The lack of sufficient number, purity, stability and homing specificity of therapeutic Tregs necessitated a dynamic platform of human Treg development on which to optimize conditions for their ex vivo expansion6.
Here we describe a method for the differentiation of induced Tregs (iTregs) from a single human peripheral blood donor which can be broken down into four stages: isolation of peripheral blood mononuclear cells, magnetic selection of CD4+ T cells, in vitro cell culture and fluorescence activated cell sorting (FACS) of T cell subsets. Since the Treg signature transcription factor forkhead box P3 (FoxP3) is an activation-induced transcription factor in humans7 and no other unique marker exists, a combinatorial panel of markers must be used to identify T cells with suppressor activity. After six days in culture, cells in our system can be demarcated into na&iuml;ve T cells, memory T cells or iTregs based on their relative expression of CD25 and CD45RA. As memory and na&iuml;ve T cells have different reported polarization requirements and plasticities8 , pre-sorting of the initial T cell population into CD45RA+ and CD45RO+ subsets can be used to examine these discrepancies. Consistent with others, our CD25HiCD45RA- iTregs express high levels of FoxP39 , GITR and CTLA-411 and low levels of CD12712 . Following FACS of each population, resultant cells can be used in a suppressor assay which evaluates the relative ability to retard the proliferation of carboxyfluorescein succinimidyl ester (CFSE)-labeled autologous T cells.

Generation of Induced Regulatory T Cells from Primary Human Na&#239;ve and Memory T Cells

We describe a method for generating regulatory, memory and na&#239;ve T cells from a single human blood donor. Polarized Tregs can be then compared to other subsets in a variety of genetic and functional applications with genetic homogeneity, including a suppression assay also detailed here.

The development and maintenance of immunosuppressive CD4+ regulatory T cells (Tregs) contribute to the peripheral tolerance needed to remain in ...

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

Finding new methods for generating human monoclonal antibodies is an active research field that is important for both basic and applied sciences, including the development of immunotherapeutics. However, the techniques to identify and produce such antibodies tend to be arduous and sometimes the heavy and light chain pair of the antibodies are dissociated. Here, we describe a relatively simple, straightforward protocol to produce human recombinant monoclonal antibodies from human peripheral blood mononuclear cells using immortalization with Epstein-Barr Virus (EBV) and Toll-like receptor 9 activation. With an adequate staining, B cells producing antibodies can be isolated for subsequent immortalization and clonal expansion. The antibody transcripts produced by the immortalized B cell clones can be amplified by PCR, sequenced as corresponding heavy and light chain pairs and cloned into immunoglobulin expression vectors. The antibodies obtained with this technique can be powerful tools to study relevant human immune responses, including autoimmunity, and create the basis for new therapeutics.

Synthesis of human monoclonal antibodies is the first step in studies aimed at unraveling the pathophysiological mechanisms of auto-antibody-mediated immune responses. We have developed a protocol to generate recombinant human immunoglobulin G (IgG) monoclonal antibodies from blood sorted B cells, including B-cell isolation, antibody cloning and in vitro synthesis.

Finding new methods for generating human monoclonal antibodies is an active research field that is important for both basic and applied sciences, ...

The Isolation, Differentiation, and Quantification of Human Antibody-secreting B Cells from Blood: ELISpot as a Functional Readout of Humoral Immunity

The hallmark of humoral immunity is to generate functional ASCs, which synthesize and secrete Abs specific to an antigen (Ag), such as a pathogen, and are used for host defense. For the quantitative determination of the functional status of the humoral immune response of an individual, both serum Abs and circulating ASCs are commonly measured as functional readouts. In humans, peripheral blood is the most convenient and readily accessible sample that can be used for the determination of the humoral immune response elicited by host B cells. Distinct B-cell subsets, including ASCs, can be isolated directly from peripheral blood via selection with lineage-specific Ab-conjugated microbeads or via cell sorting with flow cytometry. Moreover, purified na&#239;ve and memory B cells can be activated and differentiated into ASCs in culture. The functional activities of ASCs to contribute to Ab secretion can be quantified by ELISpot, which is an assay that converges enzyme-linked immunoabsorbance assay (ELISA) and western blotting technologies to enable the enumeration of individual ASCs at the single-cell level. In practice, the ELISpot assay has been increasingly used to evaluate vaccine efficacy because of the ease of handling of a large number of blood samples. The methods of isolating human B cells from peripheral blood, the differentiation of B cells into ASCs in vitro, and the employment of ELISpot for the quantification of total IgM- and IgG-ASCs will be described here.

Human peripheral blood is commonly used for the assessment of the humoral immune response. Here, the methods for isolating human B cells from peripheral blood, differentiating human B cells into antibody (Ab)-secreting B cells (ASCs) in culture, and enumerating the total IgM- and IgG-ASCs via an ELISpot assay are described.

The hallmark of humoral immunity is to generate functional ASCs, which synthesize and secrete Abs specific to an antigen (Ag), such as a pathogen, and are ...

A Simple Red Blood Cell Lysis Method for the Establishment of B Lymphoblastoid Cell Lines

A number of methods exist for the transformation of B lymphocytes by the Epstein Barr virus in vitro into immortalized cell lines. We have developed a new method with a powerful and simple strategy for the establishment of B-LCLs, the red blood cell lysis method. This method simplified the PBMC separation procedure with red blood cell removal, and used as little as 0.5 mL of whole blood for establishing EBV-immortalized cell lines, which can proliferate to large cell numbers in a relatively short amount time with a 100% success rate. The method is simple, reliable, time saving, and applicable to treating a large number of the clinical samples.

A simple red blood cell lysis method for establishing B-LCLs was developed with high immortalization efficiency, requiring a small amount of blood and saving time from initiation to cryopreservation.

A number of methods exist for the transformation of B lymphocytes by the Epstein Barr virus in vitro into immortalized cell lines. We have developed a new ...

Generation of Natural Killer Cells from Human Expanded Potential Stem Cells

The differentiation of natural killer (NK) cells from human pluripotent stem cells allows for research on and the manufacture of clinical-grade cellular products for immunotherapy. Described here is a two-phase protocol that uses a serum-free commercial medium and a cocktail of cytokines (interleukin [IL]-3, IL-7, IL-15, stem cell factor [SCF], and FMS-like tyrosine kinase 3 ligand [Ftl3L]) to differentiate human expanded potential stem cells (hEPSCs) into cells that possess NK cell properties in vitro with both 3-dimensional (3D) and 2-dimensional (2D) culture technology. Following this protocol, CD3&#8722;CD56+ or CD45+CD56+ NK cells are consistently generated. When cocultured with tumor targets for 3 h, the differentiated products display mild cytotoxicity as compared to an IL-2-independent permanent cell line, NK92mi cells. The protocol preserves the complexity of the differentiation microenvironment by the generation of 3D structures, thus facilitating the study of the spatial relationships between immune cells and their niches. Meanwhile, the 2D culture system enables the routine phenotypical validation of cell differentiation without harming the delicate differentiation niche.

The present protocol shows how to differentiate CD3&#8722;/CD45+CD56+ cells with mild cytotoxicity from human expanded potential stem cells (hEPSCs) under both 3D and 2D culture conditions. This allows for routine phenotypical validation without the destruction of the complex microenvironment.

The differentiation of natural killer (NK) cells from human pluripotent stem cells allows for research on and the manufacture of clinical-grade cellular ...

Developmental Biology

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Monoclonal antibodies (mAbs) are powerful tools useful for both fundamental research and in biomedicine. Their high specificity is indispensable when the antibody needs to distinguish between highly related structures (e.g., a normal protein and a mutated version thereof). The current way of generating such discriminative mAbs involves extensive screening of multiple Ab-producing B cells, which is both costly and time consuming. We propose here a rapid and cost-effective method for the generation of discriminative, fully human mAbs starting from human blood circulating B lymphocytes. The originality of this strategy is due to the selection of specific antigen binding B cells combined with the counter-selection of all other cells, using readily available Peripheral Blood Mononuclear Cells (PBMC). Once specific B cells are isolated, cDNA (complementary deoxyribonucleic acid) sequences coding for the corresponding mAb are obtained using single cell Reverse Transcription-Polymerase Chain Reaction (RT-PCR) technology and subsequently expressed in human cells. Within as little as 1 month, it is possible to produce milligrams of highly discriminative human mAbs directed against virtually any desired antigen naturally detected by the B cell repertoire.

We describe a method for the production of human antibodies specific for an antigen of interest, starting from rare B cells circulating in human blood. Generation of these natural antibodies is efficient and rapid, and the antibodies obtained can discriminate between highly related antigens.

Monoclonal antibodies (mAbs) are powerful tools useful for both fundamental research and in biomedicine. Their high specificity is indispensable when the ...

Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations

The human antibody repertoire represents a largely untapped source of potential therapeutic antibodies and useful biomarkers. While current computational methods, such as next generation sequencing (NGS), yield enormous sets of data on the antibody repertoire at the sequence level, functional data is required to identify which sequences are relevant for a particular antigen or set of antigens. Here, we describe a method to identify and recover individual antigen-specific antibodies from peripheral blood mononuclear cells (PBMCs) from a human blood donor. This method utilizes an initial enrichment of mature B cells and requires a combination of phenotypic cell markers and fluorescently-labeled protein to isolate IgG memory B cells via flow cytometry. The heavy and light chain variable regions are then cloned and re-screened. Although limited to the memory B cell compartment, this method takes advantage of flow cytometry to interrogate millions of B cells and returns paired heavy and light chain sequences from a single cell in a format ready for expression and confirmation of specificity. Antibodies recovered with this method can be considered for therapeutic potential, but can also link specificity and function with bioinformatic approaches to assess the B cell repertoire within individuals.

The BSelex method to identify and recover individual antigen-specific antibodies from human peripheral blood mononuclear cells combines flow cytometry with single cell PCR and cloning.

The human antibody repertoire represents a largely untapped source of potential therapeutic antibodies and useful biomarkers. While current computational ...

Induced Differentiation of M Cell-like Cells in Human Stem Cell-derived Ileal Enteroid Monolayers

M (microfold) cells of the intestine function to transport antigen from the apical lumen to the underlying Peyer&#8217;s patches and lamina propria where immune cells reside and therefore contribute to mucosal immunity in the intestine. A complete understanding of how M cells differentiate in the intestine as well as the molecular mechanisms of antigen uptake by M cells is lacking. This is because M cells are a rare population of cells in the intestine and because in vitro models for M cells are not robust. The discovery of a self-renewing stem cell culture system of the intestine, termed enteroids, has provided new possibilities for culturing M cells. Enteroids are advantageous over standard cultured cell lines because they can be differentiated into several major cell types found in the intestine, including goblet cells, Paneth cells, enteroendocrine cells and enterocytes. The cytokine RANKL is essential in M cell development, and addition of RANKL and TNF-&#945; to culture media promotes a subset of cells from ileal enteroids to differentiate into M cells. The following protocol describes a method for the differentiation of M cells in a transwell epithelial polarized monolayer system of the intestine using human ileal enteroids. This method can be applied to the study of M cell development and function.

This protocol describes how to induce the differentiation of M cells in human stem cell-derived ileal monolayers and methods to assess their development.

M (microfold) cells of the intestine function to transport antigen from the apical lumen to the underlying Peyer&#8217;s patches and lamina propria where ...

Flow Cytometric Characterization of Murine B Cell Development

Extensive studies have characterized the development and differentiation of murine B cells in secondary lymphoid organs. Antibodies secreted by B cells have been isolated and developed into well-established therapeutics. Validation of murine B cell development, in the context of autoimmune prone mice, or in mice with modified immune systems, is a crucial component of developing or testing therapeutic agents in mice and is an appropriate use of flow cytometry. Well established B cell flow cytometric parameters can be used to evaluate B cell development in the murine peritoneum, bone marrow, and spleen, but a number of best practices must be adhered to. In addition, flow cytometric analysis of B cell compartments should also complement additional readouts of B cell development. Data generated using this technique can further our understanding of wild type, autoimmune prone mouse models as well as humanized mice that can be used to generate antibody or antibody-like molecules as therapeutics.

We describe herein a simple analysis of the heterogeneity of the murine immune B cell compartment in the peritoneum, spleen, and bone marrow tissues by flow cytometry. The protocol can be adapted and extended to other mouse tissues.

Extensive studies have characterized the development and differentiation of murine B cells in secondary lymphoid organs. Antibodies secreted by B cells ...